Mumbai: A pharmacist has been duped of Rs 70 lakh along with a Kalyan-based doctor by a Thane-based doctor couple, who allegedly lured them with the promise of investing in a 50-bed hospital project. The accused and his wife, residents of Hiranandani Estate, Thane, approached Dr Rahul Dubey and pharmacist Pragya Kamble in May 2024 with a proposal to establish a hospital near the RTO office in Icon Building, Kalyan. The couple assured the victims that they would be granted rights to operate a medical store within the hospital premises. Trusting the assurances, the victims handed over ₹70 lakh to the duo, believing that the hospital would become operational within three months. The accused even signed an agreement to solidify the deal. However, despite the passage of time, no hospital came up, and the victims’ money was never returned. The Khadakpada police in Kalyan have now registered a case of fraud against the doctor couple. Times of Indiareports that the officials also suspect that the accused may have duped more doctors in a similar manner, collecting money in the name of the hospital project. A detailed probe into the matter is underway.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!